Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideABTAbbott Laboratories
FinDog View：Neutral
| Metric | ABBV | ABT |
|---|
| Close | 294.89 | 106.20 |
| Market Cap | $522B | $184B |
| 1M | +12.73% | +7.46% |
| P/E (TTM) | 81.4 | 39.1 |
| Forward P/E | 16.9 | 17.6 |
| P/E 5-Yr Percentile | 62 | 99 |
| P/S | 8.0 | 3.8 |
| P/B | — | 3.6 |
| Dividend Yield | 4.47% | 1.98% |
| Latest Quarter Revenue | $17.0B | $11.2B |
| Revenue YoY | +10.2% | +7.8% |
| Gross Margin | 74.7% | 56.2% |
| Latest Quarter EPS | 2.03 | 0.61 |
| Avg Post-Earnings Move | ±1.7% | ±1.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 2.71% |
| 90-Day Net Insider Buying | −$8.2M | −$46.9M |
ABBV · Revenue, Last 8 Quarters ($B)
ABT · Revenue, Last 8 Quarters ($B)
